Tango Therapeutics Newsroom

Tango Therapeutics Analyst Ratings

BenzingaDec 5 08:38 ET

B.Riley Financial Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Cuts Target Price to $8

Moomoo NewsNov 11 08:31 ET

Guggenheim Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $8

Moomoo NewsNov 8 07:33 ET

H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 8 07:31 ET

Promising Developments and Strategic Shifts at Tango Therapeutics: A Buy Rating With a $13 Price Target

TipRanksNov 8 07:25 ET

Tango Therapeutics Is Maintained at Buy by Guggenheim

Dow JonesNov 7 14:38 ET

Tango Therapeutics Analyst Ratings

BenzingaNov 7 14:28 ET

Barclays Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 7 03:33 ET

Barclays Keeps Their Buy Rating on Tango Therapeutics (TNGX)

TipRanksNov 7 03:28 ET

Wedbush Adjusts Tango Therapeutics Price Target to $9 From $13, Maintains Outperform Rating

MT NewswiresNov 6 11:52 ET

Tango Therapeutics Analyst Ratings

BenzingaOct 28 08:12 ET

H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsOct 28 06:34 ET

Piper Sandler Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsOct 25 08:35 ET

Leerink Partners Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsOct 15 03:32 ET

Tango Therapeutics: A Buy Rating on PRMT5 Inhibitor Prospects and Upcoming Clinical Data

TipRanksOct 15 02:47 ET

Piper Sandler Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsSep 17 12:32 ET

Barclays Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 17 04:31 ET

Barclays Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 11 03:31 ET

Tango Therapeutics Analyst Ratings

BenzingaSep 10 07:05 ET

H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 10 06:31 ET